How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,625 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. New Product Review: Intrauterine Ball (IUB) SCu300B MIDI

, the Intrauterine Ball (IUB™) SCu300B MIDI is a copper intrauterine device (Cu-IUD) comprised of copper beads with a total exposed copper surface of 300mm² strung on a flexible Nitinol (nickel/titanium alloy), PET-coated frame. Once the IUB is released from the 3.2mm diameter insertion tube into the uterus it coils into a spherical shape measuring 15mm in diameter. Download the product review in full here. Your download should start automatically. If not . Thinking about taking a qualification? Registration (...) New Product Review: Intrauterine Ball (IUB) SCu300B MIDI New Product Review: Intrauterine Ball (IUB™) SCu300B MIDI - February 2019 - Faculty of Sexual and Reproductive Healthcare New Product Review: Intrauterine Ball (IUB™) SCu300B MIDI - February 2019 New Product Review: Intrauterine Ball (IUB™) SCu300B MIDI - February 2019 Share this article 270def2e962ad577f33833df3d701209 Published on: 11 February 2019 File size: 252kb PDF File type: New Product Reviews Manufactured by OCON Medical Ltd

2019 Faculty of Sexual & Reproductive Healthcare

182. Prospective, randomized, controlled trial comparing the efficacy of intrauterine balloon and intrauterine contraceptive device in the prevention of adhesion reformation after hysteroscopic adhesiolysis. Full Text available with Trip Pro

Prospective, randomized, controlled trial comparing the efficacy of intrauterine balloon and intrauterine contraceptive device in the prevention of adhesion reformation after hysteroscopic adhesiolysis. To compare the efficacy of heart-shaped intrauterine balloon and intrauterine contraceptive device (IUD) in the prevention of adhesion reformation after hysteroscopic adhesiolysis.Prospective, randomized, controlled trial.University hospital.A total of 201 women with Asherman syndrome.Women were (...) randomized to having either a heart-shaped intrauterine balloon or an IUD fitted after hysteroscopic adhesiolysis. The devices were removed after 7 days. A second-look hysteroscopy was carried out 1 to 2 months after the surgery.Incidence of adhesion reformation and reduction of adhesion score before and after surgery.Initially 201 cases were recruited; 39 cases dropped out, resulting in 82 cases in the balloon group and 80 cases in IUD group. The age, menstrual characteristics, pregnancy history

2015 Fertility and Sterility Controlled trial quality: uncertain

183. Levonorgestrel-Releasing Intrauterine System 52 mg for Idiopathic Heavy Menstrual Bleeding

Technology Advisory Committee recommends publicly funding the 52-mg levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding Heavy menstrual bleeding can be painful, distressing and disruptive. Up to one-third of women between the ages of 15 and 55 experience heavy menstrual bleeding, and often the cause is unknown. However, treatment can reduce the symptoms and improve quality of life. Some options include medications, surgery, and a device called (...) the levonorgestrel-releasing intrauterine system. Health Quality Ontario Reviews the Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding The levonorgestrel-releasing intrauterine system is a minimally invasive and reversible device that is inserted in the uterus where it releases a hormone that suppresses and thins the lining of the uterus (endometrium), which can result in a reduction in the amount of bleeding. Currently, the insertion procedure is publicly funded in Ontario but the cost

2017 Health Quality Ontario

184. Bleeding patterns associated with intrauterine contraceptive devices

Bleeding patterns associated with intrauterine contraceptive devices Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2017 PROSPERO

185. The safety and effectiveness of the extended use of intrauterine devices: a systematic review

The safety and effectiveness of the extended use of intrauterine devices: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2017 PROSPERO

186. The mini-resectoscope, an alternative device in the treatment of intrauterine pathologies: a systematic review

The mini-resectoscope, an alternative device in the treatment of intrauterine pathologies: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

187. Flowchart: Stable intrauterine non-viable pregnancy

• Pregnancy is not viable Discuss care options relevant to woman’s preferences and clinical indications Queensland Clinical Guidelines: Early pregnancy loss F17.29-1-V4-R22 ß-hCG: human chorionic gonadtrophin, EPAS: early pregnancy assessment service, FBC: full blood count, GP: General Practitioner, GTD: gestational trophoblast disease, IUD: intrauterine device, IUP: Intrauterine pregnancy, POC: products of conception, PUL: pregnancy of unknown location, PV: per vaginam, QTC: Queensland Trophoblast Centre (...) Flowchart: Stable intrauterine non-viable pregnancy Queensland Health State of Queensland (Queensland Health) 2017 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Queensland Clinical Guidelines www.health.qld.gov.au/qcg Stable intrauterine non-viable pregnancy Expectant Indications • Woman’s preference • Incomplete miscarriage Contraindications • Haemodynamic instability • Suspected GTD • IUD (must be removed) • Risk

2017 Queensland Health

188. Chronic vulvovaginal candidiasis in patients using a levonorgestrel-containing intrauterine device. (Abstract)

Chronic vulvovaginal candidiasis in patients using a levonorgestrel-containing intrauterine device. Chronic vulvovaginal candidiasis is usually responsive to therapy with oral antifungals. We present a case series of 13 patients with this condition who were also using a levonorgestrel intrauterine system (LNG-IUS). All cases responded to ongoing oral fluconazole therapy while the LNG-IUS was in situ. The LNG-IUS was removed in six patients and of these, two experienced clinical improvement

2016 Australasian Journal of Dermatology

189. Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: A randomized double-blind controlled trial. (Abstract)

Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: A randomized double-blind controlled trial. The objective was to investigate the analgesic effect of cervical lidocaine-prilocaine (LP) cream in alleviating pain during copper T380A intrauterine device (IUD) insertion among parous women.We conducted a randomized, double-blind, placebo-controlled trial at Assiut Women's Health Hospital, Egypt, from October 2015

2016 Contraception Controlled trial quality: predicted high

190. Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial. (Abstract)

Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial. To evaluate whether 550 mg oral naproxen sodium given 1 hour before intrauterine device (IUD) insertion is effective for pain relief as compared with placebo.This was a randomized, double-blind, placebo-controlled trial. The primary outcome was pain with IUD insertion measured on a 100-mm visual analog scale (VAS). Our sample size was calculated to detect a 15-mm difference in VAS scores with 80

2016 Obstetrics and Gynecology Controlled trial quality: predicted high

191. New developments in long-acting reversible contraception: the promise of intrauterine devices and implants to improve family planning services. Full Text available with Trip Pro

New developments in long-acting reversible contraception: the promise of intrauterine devices and implants to improve family planning services. After decades of having the developed world's highest rates of unintended pregnancy, the United States finally shows signs of improvement. This progress is likely due in large part to increased use of highly effective long-acting reversible methods of contraception. These methods can be placed and do not require any maintenance to provide years

2016 Fertility and Sterility

192. Safety and Efficacy of a 52 mg Levonorgestrel-medicated intrauterine device: A Seven Year Randomized Comparative Study with the TCu380A. Full Text available with Trip Pro

Safety and Efficacy of a 52 mg Levonorgestrel-medicated intrauterine device: A Seven Year Randomized Comparative Study with the TCu380A. To compare rates of unintended pregnancy, method continuation and reasons for removal among women using the 52-mg levonorgestrel (daily release 20 microg) levonorgestrel IUD (LNG-IUD) or the copper T 380A (TCu380A) intrauterine device.This was an open-label 7-year randomized controlled trial in 20 centres, 11 of which in China. Data on 1884 women with interval (...) ] per 100), particularly in Chinese women and, for the TCu380A, increased bleeding (9.9 [0.9] per 100), especially among non-Chinese women. Removal rates for pain were similar for the two intrauterine devices (IUDs). Cumulative rates of removal for symptoms compatible with hormonal side effects were 5.7 (0.7) and 0.4 (0.2) per 100 for the LNG-IUD and TCu380A, respectively, and cumulative losses to follow-up at 7 years were 26.0 (1.4) and 36.9 (1.3) per 100, respectively.The LNG-IUD and the TCu380A

2016 Contraception Controlled trial quality: uncertain

193. Use of effective contraception six months after emergency contraception with a copper intrauterine device or ulipristal acetate - a prospective observational cohort study. Full Text available with Trip Pro

Use of effective contraception six months after emergency contraception with a copper intrauterine device or ulipristal acetate - a prospective observational cohort study. Emergency contraception must be followed by the use of an effective method of contraception in order to reduce future risk of unintended pregnancies. Provision of long-acting reversible contraception (LARC) is highly effective in this regard. The aim of our study was to compare use of an effective method of contraception 6 (...) months following insertion of a copper intrauterine device (Cu-IUD) or intake of ulipristal acetate (UPA) for emergency contraception (EC).Women (n = 79) presenting with need for EC at an outpatient midwifery clinic chose either Cu-IUD or UPA according to preference. Follow up was 3 and 6 months later through telephone interviews. Primary outcome was use of an effective contraceptive method at the 6-month follow up. Secondary outcomes included use of an effective contraceptive method at 3 months

2016 Acta Obstetricia et Gynecologica Scandinavica

194. A Dedicated Postpartum Intrauterine Device Inserter: Pilot Experience and Proof of Concept. Full Text available with Trip Pro

A Dedicated Postpartum Intrauterine Device Inserter: Pilot Experience and Proof of Concept. To assess the feasibility, acceptability, and safety of a dedicated postpartum intrauterine device (PPIUD) inserter specifically designed for the post-delivery setting. Primary objectives of fundal placement and expulsion rates were assessed. Secondary objectives were participant satisfaction and IUD retention.In this pilot proof of concept, we enrolled 80 women who presented for PPIUD insertion at 2

2016 Global health, science and practice

195. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. Full Text available with Trip Pro

Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. The copper intrauterine device (IUD) is under-utilised in South Africa, where injectable progestin contraception (IPC) dominates contraception usage. There is a lack of robust comparative data on these contraceptive options to inform policy, programs

2016 Reproductive health Controlled trial quality: predicted high

196. Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion . A randomized double blinded placebo-controlled study. (Abstract)

Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion . A randomized double blinded placebo-controlled study. To determine the effectiveness of diclofenac potassium combined with 2% lidocaine gel in reducing the pain of intrauterine device (IUD) insertion.We randomized 90 parous women requesting copper T380A IUD insertion in a 1:1 ratio to active or placebo treatment. Active treatment included administration of two 50-mg diclofenac potassium tablets 1h before IUD

2016 Contraception Controlled trial quality: predicted high

197. Corrigendum to "Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A" [Contraception 2016;93:498-506]. Full Text available with Trip Pro

Corrigendum to "Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A" [Contraception 2016;93:498-506]. 27312266 2018 11 13 1879-0518 94 3 2016 Sep Contraception Contraception Corrigendum to "Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A" [Contraception 2016;93:498-506]. 288

2016 Contraception Controlled trial quality: uncertain

198. Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices. (Abstract)

Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices. To determine if there are any differences in the patient populations that choose subdermal implants versus intrauterine devices (IUDs) for contraceptive purposes.Retrospective chart review. Electronic medical records of women who presented to the University of Texas Medical Branch in Galveston's Regional Maternal Child Health Program Clinics in southeast Texas from March 2011 to March 2013 and received a subdermal

2016 Journal of Reproductive Medicine

199. Reasons for Intrauterine Device Use, Discontinuation and Non-Use in Malawi: A Qualitative Study of Women and their Partners. (Abstract)

Reasons for Intrauterine Device Use, Discontinuation and Non-Use in Malawi: A Qualitative Study of Women and their Partners. The copper intrauterine device (IUD) is a safe, long-acting, and effective method of contraception that is under-utilized in many countries, including Malawi. A unique cohort of women who had enrolled in a trial of postpartum IUD use one year earlier gave insights into reasons for using, discontinuing, or not using the IUD. We conducted in-depth interviews with 18 women

2016 African journal of reproductive health Controlled trial quality: uncertain

200. Association of Intrauterine Device (IUD) and Cervical Neoplasia - A Study in a Poor Nigerian Population Full Text available with Trip Pro

Association of Intrauterine Device (IUD) and Cervical Neoplasia - A Study in a Poor Nigerian Population Intrauterine Device (IUD) is a contraceptive method used by women of reproductive age group. However, there are conflicting reports on the association between IUD and cervical neoplasia. These controversies may further hamper the poor uptake of modern contraception in Nigeria.This study was therefore aimed at evaluating the association between IUD and cervical neoplasia.This was a case

2016 Journal of clinical and diagnostic research : JCDR

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>